These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31694343)

  • 1. Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation.
    Ninio L; Nissani A; Meirson T; Domovitz T; Genna A; Twafra S; Srikanth KD; Dabour R; Avraham E; Davidovich A; Gil-Henn H; Gal-Tanamy M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31694343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
    Perez S; Kaspi A; Domovitz T; Davidovich A; Lavi-Itzkovitz A; Meirson T; Alison Holmes J; Dai CY; Huang CF; Chung RT; Nimer A; El-Osta A; Yaari G; Stemmer SM; Yu ML; Haviv I; Gal-Tanamy M
    PLoS Genet; 2019 Jun; 15(6):e1008181. PubMed ID: 31216276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus NS3 protein enhances hepatocellular carcinoma cell invasion by promoting PPM1A ubiquitination and degradation.
    Zhou Y; Zhao Y; Gao Y; Hu W; Qu Y; Lou N; Zhu Y; Zhang X; Yang H
    J Exp Clin Cancer Res; 2017 Mar; 36(1):42. PubMed ID: 28283039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus Mediated Metastasis in Hepatocellular Carcinoma as a Therapeutic Target for Cancer Management.
    Khera L; Paul C; Kaul R
    Curr Drug Metab; 2018; 19(3):224-235. PubMed ID: 29380693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus core protein interacts with cellular metastasis suppressor Nm23-H1 and promotes cell migration and invasion.
    Paul C; Khera L; Kaul R
    Arch Virol; 2019 May; 164(5):1271-1285. PubMed ID: 30859475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming.
    Liu Y; Lu LL; Wen D; Liu DL; Dong LL; Gao DM; Bian XY; Zhou J; Fan J; Wu WZ
    J Hematol Oncol; 2020 Feb; 13(1):12. PubMed ID: 32033570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK/p38/NF-κB signal cascade.
    Lu L; Zhang Q; Wu K; Chen X; Zheng Y; Zhu C; Wu J
    Cancer Lett; 2015 Jan; 356(2 Pt B):470-8. PubMed ID: 25305454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.
    Cevik O; Li D; Baljinnyam E; Manvar D; Pimenta EM; Waris G; Barnes BJ; Kaushik-Basu N
    J Biol Chem; 2017 Dec; 292(52):21676-21689. PubMed ID: 29079574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
    Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
    Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor.
    Khalid M; Manzoor S; Ahmad H; Asif A; Bangash TA; Latif A; Jaleel S
    Mol Biol Rep; 2018 Dec; 45(6):2625-2630. PubMed ID: 30343397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Gene Expression during Hepatitis C Virus Replication as Revealed by Ribosome Profiling.
    Gerresheim GK; Bathke J; Michel AM; Andreev DE; Shalamova LA; Rossbach O; Hu P; Glebe D; Fricke M; Marz M; Goesmann A; Kiniry SJ; Baranov PV; Shatsky IN; Niepmann M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals.
    Hazari S; Hefler HJ; Chandra PK; Poat B; Gunduz F; Ooms T; Wu T; Balart LA; Dash S
    World J Gastroenterol; 2011 Jan; 17(3):300-12. PubMed ID: 21253388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response.
    Wang Y; Jiang Y; Zhou J; Song W; Li J; Wang M; Chen J; Xu R; Zhang J; Ma F; Chen YH; Ma Y
    Tumour Biol; 2016 Nov; 37(11):15265-15274. PubMed ID: 27696294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis.
    Virzì A; Roca Suarez AA; Baumert TF; Lupberger J
    Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31501266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus.
    Takeda H; Takai A; Iguchi E; Mishima M; Arasawa S; Kumagai K; Eso Y; Shimizu T; Takahashi K; Ueda Y; Taura K; Hatano E; Iijima H; Aoyagi H; Aizaki H; Marusawa H; Wakita T; Seno H
    Carcinogenesis; 2021 May; 42(5):672-684. PubMed ID: 33617626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation.
    Peng X; Li X; Yang S; Huang M; Wei S; Ma Y; Li Y; Wu B; Jin H; Li B; Tang S; Fan Q; Liu J; Yang L; Li H
    J Exp Clin Cancer Res; 2021 Jun; 40(1):183. PubMed ID: 34088337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
    Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
    Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.